Skip to main content
CriticalFDAfda-F-0622-2013UNDECLARED ALLERGEN

Hannaford Triple Chocolate Cake Truffle, 6 count UPC # 20335700000

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Units Affected
0
Recall Date
October 11, 2012
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0622-2013.

Product labels fails to declare allergens: egg, milk, peanuts, wheat, soy and tree nuts

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0622-2013.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Hannaford Bros. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0622-2013.

Hannaford Bros.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Hannaford Bros. Recall FAQ

Hannaford Bros. is the subject of a bakery & grains safety report: Hannaford Triple Chocolate Cake Truffle, 6 count UPC # 20335700000. The notice was published on October 11, 2012 by the U.S. Food and Drug Administration (FDA). Approximately 0 units are potentially affected.